Ryan M Kemper

6PUBLICATIONS
38CO-AUTHORS
Molecular targetsTransplantation immunologyCell physiologyHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 16, 2025
A First-in-Class Chemical-Induced Proximity System Achieves Dose-Dependent Control of Tumor Protein P53 Gene Activation in Preclinical Models of Gastric Cancer.

Travis J Nelson, Ryan M Kemper, Anna M Chiarella

|Aug 12, 2025
A Tacrolimus Population Pharmacokinetic Model for Adult Allogeneic Hematopoietic Cell Transplant Recipients Provides Clinical Opportunities for Precision Dosing.

Tyler C Dunlap, Jing Zhu, Daniel L Weiner

|Jul 11, 2024
Use of allopurinol to manage skewed 6-mercaptopurine metabolism in pediatric maintenance acute lymphoblastic leukemia treatment.

Mandee Lines, Ryan M Kemper, Jordan Wallace

|May 01, 2023
Utilization of a Population Pharmacokinetic Model to Improve a Busulfan Test-Dose Strategy in Allogeneic Hematopoietic Cell Transplant Recipients.

Tyler C Dunlap, Daniel L Weiner, Ryan M Kemper

|Nov 09, 2021
Tolerability of palbociclib in younger and older patients with advanced breast cancer.

Taylor Dennison, Hillary Heiling, Allison Deal

|Aug 18, 2021
Pharmacokinetics of perioperative FVIII in adult patients with haemophilia A: An external validation and development of an alternative population pharmacokinetic model.

Jing Zhu, Yi Shuan Wu, Ryan J Beechinor

Pageof 1

Frequent Collaborators

3 joint publications

Daniel J Crona

2 joint publications

Jing Zhu

2 joint publications

Paul M Armistead

2 joint publications

J Ryan Shaw